Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Chem Biol ; 3(5): 274-7, 2007 May.
Article in English | MEDLINE | ID: mdl-17438551

ABSTRACT

Terpenoids are a highly diverse class of natural products that have historically provided a rich source for discovery of pharmacologically active small molecules, such as paclitaxel (Taxol) and artemisinin. Unfortunately, these secondary metabolites are typically produced in low abundance in their host organism, and their isolation consequently suffers from low yields and high consumption of natural resources. Furthermore, chemical synthesis of terpenoids can also be difficult to scale for industrial production. For these reasons, an attractive alternative strategy is to engineer metabolic pathways for production of pharmaceuticals or their precursors in a microbial host such as Escherichia coli. A key step is developing methods to carry out cytochrome P450 (P450)-based oxidation chemistry in vivo. Toward this goal, we have assembled two heterologous pathways for the biosynthesis of plant-derived terpenoid natural products, and we present the first examples of in vivo production of functionalized terpenoids in E. coli at high titer using native plant P450s.


Subject(s)
Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Escherichia coli/metabolism , Plants/enzymology , Terpenes/metabolism , Artemisinins/chemistry , Artemisinins/metabolism , Escherichia coli/genetics , Molecular Structure , Protein Engineering , Terpenes/chemistry
2.
Nature ; 440(7086): 940-3, 2006 Apr 13.
Article in English | MEDLINE | ID: mdl-16612385

ABSTRACT

Malaria is a global health problem that threatens 300-500 million people and kills more than one million people annually. Disease control is hampered by the occurrence of multi-drug-resistant strains of the malaria parasite Plasmodium falciparum. Synthetic antimalarial drugs and malarial vaccines are currently being developed, but their efficacy against malaria awaits rigorous clinical testing. Artemisinin, a sesquiterpene lactone endoperoxide extracted from Artemisia annua L (family Asteraceae; commonly known as sweet wormwood), is highly effective against multi-drug-resistant Plasmodium spp., but is in short supply and unaffordable to most malaria sufferers. Although total synthesis of artemisinin is difficult and costly, the semi-synthesis of artemisinin or any derivative from microbially sourced artemisinic acid, its immediate precursor, could be a cost-effective, environmentally friendly, high-quality and reliable source of artemisinin. Here we report the engineering of Saccharomyces cerevisiae to produce high titres (up to 100 mg l(-1)) of artemisinic acid using an engineered mevalonate pathway, amorphadiene synthase, and a novel cytochrome P450 monooxygenase (CYP71AV1) from A. annua that performs a three-step oxidation of amorpha-4,11-diene to artemisinic acid. The synthesized artemisinic acid is transported out and retained on the outside of the engineered yeast, meaning that a simple and inexpensive purification process can be used to obtain the desired product. Although the engineered yeast is already capable of producing artemisinic acid at a significantly higher specific productivity than A. annua, yield optimization and industrial scale-up will be required to raise artemisinic acid production to a level high enough to reduce artemisinin combination therapies to significantly below their current prices.


Subject(s)
Antimalarials/metabolism , Artemisinins/metabolism , Genetic Engineering , Malaria, Falciparum/drug therapy , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Sesquiterpenes/metabolism , Animals , Antimalarials/chemistry , Antimalarials/economics , Artemisia annua/enzymology , Artemisia annua/genetics , Artemisinins/chemistry , Artemisinins/economics , Bioreactors , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Drug Costs/trends , Fermentation , Gas Chromatography-Mass Spectrometry , Malaria, Falciparum/economics , Mevalonic Acid/metabolism , Molecular Sequence Data , Plasmodium falciparum , Sesquiterpenes/chemistry , Sesquiterpenes/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...